NHG-Standaard
M50
3.0
november 2020
november 2020
W/X/Y. Zwangerschap / anticonceptie / geslachtsorganen man en vrouw
Richtlijnen diagnostiek
Naar Volledige tekst ›Anamnese
Naar Volledige tekst ›Lichamelijk onderzoek
Naar Volledige tekst ›Aanvullend onderzoek
Naar Volledige tekst ›Evaluatie
Naar Volledige tekst ›Richtlijnen beleid
Naar Volledige tekst ›Voorlichting
Naar Volledige tekst ›Niet-medicamenteuze behandeling
Naar Volledige tekst ›Medicamenteuze behandeling
Naar Volledige tekst ›Antibiotica
Naar Volledige tekst ›Aanvullend beleid
Naar Volledige tekst ›Controles
Naar Volledige tekst ›Consultatie en verwijzing
Naar Volledige tekst ›Inleiding
Naar Samenvatting ›Scope
Naar Samenvatting ›Buiten de scope
Naar Samenvatting ›Samenwerking en afstemming
Naar Samenvatting ›Achtergronden
Naar Samenvatting ›Begrippen
Naar Samenvatting ›Epidemiologie
Naar Samenvatting ›Etiologie en pathofysiologie
Naar Samenvatting ›Algemeen
Naar Samenvatting ›Risicofactoren
Naar Samenvatting ›Pathogenese
Naar Samenvatting ›Verwekkers
Naar Samenvatting ›Mycoplasma genitalium bij PID
Naar Samenvatting ›Prognose
Naar Samenvatting ›Richtlijnen diagnostiek
Naar Samenvatting ›Anamnese
Naar Samenvatting ›Lichamelijk onderzoek
Naar Samenvatting ›Aanvullend onderzoek
Naar Samenvatting ›Soatests
Naar Samenvatting ›Overige tests
Naar Samenvatting ›Echografie
Naar Samenvatting ›Evaluatie
Naar Samenvatting ›Differentiaaldiagnose
Naar Samenvatting ›Richtlijnen beleid
Naar Samenvatting ›Voorlichting en advies
Naar Samenvatting ›Ziektebeeld en beloop
Naar Samenvatting ›Thuisarts
Naar Samenvatting ›Beleid bij spiraal
Naar Samenvatting ›Medicamenteuze behandeling
Naar Samenvatting ›Algemeen
Naar Samenvatting ›Antibiotica
Naar Samenvatting ›Aanvullend beleid
Naar Samenvatting ›Controles
Naar Samenvatting ›Consultatie en verwijzing
Naar Samenvatting ›Referenties
- Nielen MM, Hek K, Schermer TR. Incidentie en prevalentie van gezondheidsproblemen in de Nederlandse huisartsenpraktijk in 2018. Utrecht: NIVEL, 2018. www.nivel.nl, geraadpleegd 31-03-2020.
- Chan Y, Parchment W, Skurnick JH, Goldsmith L, Apuzzio JJ. Epidemiology and clinical outcome of patients hospitalized with pelvic inflammatory disease complicated by tubo-ovarian abscess. Infect Dis Obstet Gynecol 1995;3:135-9.
- Lee SW, Rhim CC, Kim JH, Lee SJ, Yoo SH, Kim SY, et al. Predictive markers of tubo-ovarian abscess in pelvic inflammatory disease. Gynecol Obstet Invest 2015 Apr 23. [Online ahead of print]
- Slap GB, Forke CM, Cnaan A, Bellah RD, Kreider ME, Hanissian JA, et al. Recognition of tubo-ovarian abscess in adolescents with pelvic inflammatory disease. J Adolesc Health 1996;18:397-403.
- Risser WL, Risser JM, Benjamins LJ, Feldmann JM. Incidence of Fitz-Hugh-Curtis syndrome in adolescents who have pelvic inflammatory disease. J Pediatr Adolesc Gynecol 2007;20:179-80.
- Simms I, Stephenson JM, Mallinson H, Peeling RW, Thomas K, Gokhale R, et al. Risk factors associated with pelvic inflammatory disease. Sex Transm Infect 2006;82:452-7.
- Hay PE, Kerry SR, Normansell R, Horner PJ, Reid F, Kerry SM, et al. Which sexually active young female students are most at risk of pelvic inflammatory disease? A prospective study. Sex Transm Infect 2016;92:63-6.
- O DF, Roskams T, Van den Eynde K, Vanhie A, Peterse DP, Meuleman C, et al. The presence of endometrial cells in peritoneal fluid of women with and without endometriosis. Reprod Sci 2017;24:242-51.
- Levgur M, Duvivier R. Pelvic inflammatory disease after tubal sterilization: a review. Obstet Gynecol Surv 2000;55:41-50.
- Ness RB, Hillier SL, Kip KE, Soper DE, Stamm CA, McGregor JA, et al. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol 2004;104:761-9.
- Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992;339:785-8.
- Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet 2000;356:1013-9.
- Jatlaoui TC, Riley HE, Curtis KM. The safety of intrauterine devices among young women: a systematic review. Contraception 2017;95:17-39.
- Hafner LM. Pathogenesis of fallopian tube damage caused by Chlamydia trachomatis infections. Contraception 2015;92:108-15.
- Trautmann GM, Kip KE, Richter HE, Soper DE, Peipert JF, Nelson DB, et al. Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease? Am J Obstet Gynecol 2008;198:30.e1-7.
- Schindlbeck C, Dziura D, Mylonas I. Diagnosis of pelvic inflammatory disease (PID): intra-operative findings and comparison of vaginal and intra-abdominal cultures. Arch Gynecol Obstet 2014;289:1263-9.
- Wang Y, Zhang Y, Zhang Q, Chen H, Feng Y. Characterization of pelvic and cervical microbiotas from patients with pelvic inflammatory disease. J Med Microbiol 2018;67:1519-26.
- Goller JL, De Livera AM, Fairley CK, Guy RJ, Bradshaw CS, Chen MY, et al. Characteristics of pelvic inflammatory disease where no sexually transmitted infection is identified: a cross-sectional analysis of routinely collected sexual health clinic data. Sex Transm Infect 2017;93:68-70.
- Judlin P. Current concepts in managing pelvic inflammatory disease. Curr Opin Infect Dis 2010;23:83-7.
- Ness RB, Trautmann G, Richter HE, Randall H, Peipert JF, Nelson DB, et al. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Obstet Gynecol 2005;106:573-80.
- NVOG. Pelvic inflammatory disease. Utrecht: Nederlandse Vereniging voor Obstetrie en Gynaecologie, 2020. Geraadpleegd juli 2020. Ga naar bron: NVOG. Pelvic inflammatory disease. Utrecht: Nederlandse Vereniging voor Obstetrie en Gynaecologie, 2020. Geraadpleegd juli 2020.
- Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis 2015;61:418-26.
- Cina M, Baumann L, Egli-Gany D, Halbeisen FS, Ali H, Scott P, et al. Mycoplasma genitalium incidence, persistence, concordance between partners and progression: systematic review and meta-analysis. Sex Transm Infect 2019;95:328-35.
- Jurstrand M, Jensen JS, Magnuson A, Kamwendo F, Fredlund H. A serological study of the role of Mycoplasma genitalium in pelvic inflammatory disease and ectopic pregnancy. Sex Transm Infect 2007;83:319-23.
- Lind K, Kristensen GB. Significance of antibodies to Mycoplasma genitalium in salpingitis. Eur J Clin Microbiol 1987;6:205-7.
- Taylor-Robinson D, Jensen JS, Svenstrup H, Stacey CM. Difficulties experienced in defining the microbial cause of pelvic inflammatory disease. Int J STD AIDS 2012;23:18-24.
- Oakeshott P, Aghaizu A, Hay P, Reid F, Kerry S, Atherton H, et al. Is Mycoplasma genitalium in women the ‘new Chlamydia’? A community-based prospective cohort study. Clin Infect Dis 2010;51:1160-6.
- Vandepitte J, Bukenya J, Hughes P, Muller E, Buve A, Hayes R, et al. Clinical characteristics associated with Mycoplasma genitalium infection among women at high risk of HIV and other STI in Uganda. Sex Transm Dis 2012;39:487-91.
- Cohen CR, Manhart LE, Bukusi EA, Astete S, Brunham RC, Holmes KK, et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002;359:765-6.
- Haggerty CL. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Curr Opin Infect Dis 2008;21:65-9.
- Simms I, Warburton F, Westrom L. Diagnosis of pelvic inflammatory disease: time for a rethink. Sex Transm Infect 2003;79:491-4.
- Bjartling C, Osser S, Persson K. The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy. BJOG 2010;117:361-4.
- Bjartling C, Osser S, Persson K. Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service. Am J Obstet Gynecol 2012;206:476.e1-8.
- Chayachinda C, Rekhawasin T. Reproductive outcomes of patients being hospitalised with pelvic inflammatory disease. J Obstet Gynaecol 2017;37:228-32.
- Trent M, Bass D, Ness RB, Haggerty C. Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study. Sex Transm Dis 2011;38:879-81.
- Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992;19:185-92.
- Ness RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: Results from the pelvic inflammatory disease evaluation and clinical health (PEACH) randomized trial. Am J Obstet Gynecol 2002;186:929-37.
- Hemilä M, Henriksson L, Ylikorkala O. Serum CRP in the diagnosis and treatment of pelvic inflammatory disease. Arch Gynecol Obstet 1987;241:177-82.
- Lehtinen M, Laine S, Heinonen PK, Teisala K, Miettinen A, Aine R, et al. Serum C-reactive protein determination in acute pelvic inflammatory disease. Am J Obstet Gynecol 1986;154:158-9.
- Miettinen AK, Heinonen PK, Laippala P, Paavonen J. Test performance of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of acute pelvic inflammatory disease. Am J Obstet Gynecol 1993;169:1143-9.
- Peipert JF, Boardman L, Hogan JW, Sung J, Mayer KH. Laboratory evaluation of acute upper genital tract infection. Obstet Gynecol 1996;87:730-6.
- Schmidt-Rhode P, Schulz KD, Sturm G, Prinz H. C-reactive protein is a marker for the diagnosis of adnexitis. Int J Gynaecol Obstet 1990;32:133-9.
- Hajj SN, Angerman NS, Evans MI, Moravec WD, Schumacher GF. C-reactive protein in the differential diagnosis of gynecologic pathology. J Reprod Med 1979;23:284-7.
- Jacobson L, Laurell C-B, Gennser G, Marholev K. Plasma protein changes induced by acute inflammation of the fallopian tubes. International Journal of Gynecology & Obstetrics 1975;13:249-56.
- Wasserheit JN, Bell TA, Kiviat NB, Wolner-Hanssen P, Zabriskie V, Kirby BD, et al. Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med 1986;104:187-93.
- Blenning CE, Muench J, Judkins DZ, Roberts KT. Clinical inquiries. Which tests are most useful for diagnosing PID? J Fam Pract 2007;56:216-20.
- Munday PE. Pelvic inflammatory disease--an evidence-based approach to diagnosis. J Infect 2000;40:31-41.
- Romosan G, Valentin L. The sensitivity and specificity of transvaginal ultrasound with regard to acute pelvic inflammatory disease: a review of the literature. Arch Gynecol Obstet 2014;289:705-14.
- Patten RM, Vincent LM, Wolner-Hanssen P, Thorpe E Jr. Pelvic inflammatory disease. Endovaginal sonography with laparoscopic correlation. J Ultrasound Med 1990;9:681-9.
- Cacciatore B, Leminen A, Ingman-Friberg S, Ylostalo P, Paavonen J. Transvaginal sonographic findings in ambulatory patients with suspected pelvic inflammatory disease. Obstet Gynecol 1992;80:912-6.
- Boardman LA, Peipert JF, Brody JM, Cooper AS, Sung J. Endovaginal sonography for the diagnosis of upper genital tract infection. Obstet Gynecol 1997;90(1):54-7.
- Timor-Tritsch IE, Lerner JP, Monteagudo A, Murphy KE, Heller DS. Transvaginal sonographic markers of tubal inflammatory disease. Ultrasound Obstet Gynecol 1998;12:56-66.
- Tukeva TA, Aronen HJ, Karjalainen PT, Molander P, Paavonen T, Paavonen J. MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US. Radiology 1999;210:209-16.
- Molander P, Sjoberg J, Paavonen J, Cacciatore B. Transvaginal power Doppler findings in laparoscopically proven acute pelvic inflammatory disease. Ultrasound Obstet Gynecol 2001;17:233-8.
- Romosan G, Bjartling C, Skoog L, Valentin L. Ultrasound for diagnosing acute salpingitis: a prospective observational diagnostic study. Hum Reprod 2013;28:1569-79.
- Farrukh S, Sivitz AB, Onogul B, Patel K, Tejani C. The Additive Value of Pelvic Examinations to History in Predicting Sexually Transmitted Infections for Young Female Patients With Suspected Cervicitis or Pelvic Inflammatory Disease. Ann Emerg Med 2018;72:703-12.e1.
- Kahn JG, Walker CK, Washington AE, Landers DV, Sweet RL. Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model. JAMA 1991;266:2594-604.
- Peipert JF, Ness RB, Blume J, Soper DE, Holley R, Randall H, et al. Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease. Am J Obstet Gynecol 2001;184:856-63; discussion 63-4.
- Jacobson L, Westrom L. Objectivized diagnosis of acute pelvic inflammatory disease: Diagnostic and prognostic value of routine laparoscopy. Am J Obstet Gynecol 1969;105:1088-98.
- Wolner-Hanssen P, Mardh PA, Svensson L, Westrom L. Laparoscopy in women with chlamydial infection and pelvic pain: a comparison of patients with and without salpingitis. Obstet Gynecol 1983;61:299-303.
- Tepper NK, Steenland MW, Gaffield ME, Marchbanks PA, Curtis KM. Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review. Contraception 2013;87:655-60.
- Teisala K. Removal of an intrauterine device and the treatment of acute pelvic inflammatory disease. Ann Med 1989;21:63-5.
- Larsson B, Wennergren M. Investigation of a copper-intrauterine device (Cu-IUD) for possible effect on frequency and healing of pelvic inflammatory disease. Contraception 1977;15:143-9.
- Söderberg G, Lindgren S. Influence of an intrauterine device on the course of an acute salpingitis. Contraception 1981;24:137-43.
- Altunyurt S, Demir N, Posaci C. A randomized controlled trial of coil removal prior to treatment of pelvic inflammatory disease. Eur J Obstet Gynecol Reprod Biol 2003;107:81-4.
- Savaris RF, Fuhrich DG, Duarte RV, Franik S, Ross J. Antibiotic therapy for pelvic inflammatory disease. Cochrane Database Syst Rev 2017;4:CD010285.
- Petrina MA, Cosentino LA, Wiesenfeld HC, Darville T, Hillier SL. Susceptibility of endometrial isolates recovered from women with clinical pelvic inflammatory disease or histological endometritis to antimicrobial agents. Anaerobe 2019;56:61-5.
- Savaris RF, Fuhrich DG, Maissiat J, Duarte RV, Ross J. Antibiotic therapy for pelvic inflammatory disease. Cochrane Database Syst Rev 2020;8:CD010285.
- Bevan CD, Johal BJ, Mumtaz G, Ridgway GL, Siddle NC. Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort. Br J Obstet.Gynaecol 1995;102:407-14.
- Hadgu A, Westrom L, Brooks CA, Reynolds GH, Thompson SE. Predicting acute pelvic inflammatory disease: a multivariate analysis. Am.J Obstet.Gynecol 1986;155:954-60.
- Korn AP, Hessol N, Padian N, Bolan G, Muzsnai D, Donegan E, et al. Commonly used diagnostic criteria for pelvic inflammatory disease have poor sensitivity for plasma cell endometritis. Sex Transm Dis 1995;22:335-41.
- Livengood CH, 3rd, Hill GB, Addison WA. Pelvic inflammatory disease: findings during inpatient treatment of clinically severe, laparoscopy-documented disease. Am J Obstet Gynecol 1992;166:519-24.